Low-energy red light radiation improves antitumor activity of cyclophosphamide.
Exposure of rats with Pliss lymphosarcoma to incoherent red light according to certain protocols creates conditions preventing suppression of antitumor resistance, reducing the toxic effect of cyclophosphamide, and potentiating its antitumor effect.